Search research articles
Contact Us
Filters
Showing results (221-230 of 299) with videos related to
Page
of 30
Sort By:
Investigational New Drugs
|
November 27, 2012
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors
Jeffrey R Infante, Silvia Novello, Wen Wee Ma, et al.
Elife
|
March 16, 2016
Molecular shifts in limb identity underlie development of feathered feet in two domestic avian species
Eric T Domyan, Zev Kronenberg, Carlos R Infante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors
Jeffrey R Infante, D Ross Camidge, Linda R Mileshkin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 6, 2012
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer
David R Spigel, F Anthony Greco, David M Waterhouse, et al.
British Journal of Cancer
|
January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
Jeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
British Journal of Cancer
|
September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
Jeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Developmental Biology
|
December 20, 2011
Somitogenesis in the anole lizard and alligator reveals evolutionary convergence and divergence in the amniote segmentation clock
Walter L Eckalbar, Eris Lasku, Carlos R Infante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2016
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
David F McDermott, Jeffrey A Sosman, Mario Sznol, et al.
Investigational New Drugs
|
September 26, 2015
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin
Jhanelle E Gray, Jeffrey R Infante, Les H Brail, et al.
Molecular Cancer Therapeutics
|
June 9, 2012
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors
Howard A Burris, Afshin Dowlati, Rebecca A Moss, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 299) with videos related to
Sort By:
Page
of 30
Investigational New Drugs
|
November 27, 2012
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors
Jeffrey R Infante, Silvia Novello, Wen Wee Ma, et al.
Elife
|
March 16, 2016
Molecular shifts in limb identity underlie development of feathered feet in two domestic avian species
Eric T Domyan, Zev Kronenberg, Carlos R Infante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2012
Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors
Jeffrey R Infante, D Ross Camidge, Linda R Mileshkin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 6, 2012
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer
David R Spigel, F Anthony Greco, David M Waterhouse, et al.
British Journal of Cancer
|
January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
Jeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
British Journal of Cancer
|
September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
Jeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Developmental Biology
|
December 20, 2011
Somitogenesis in the anole lizard and alligator reveals evolutionary convergence and divergence in the amniote segmentation clock
Walter L Eckalbar, Eris Lasku, Carlos R Infante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2016
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
David F McDermott, Jeffrey A Sosman, Mario Sznol, et al.
Investigational New Drugs
|
September 26, 2015
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin
Jhanelle E Gray, Jeffrey R Infante, Les H Brail, et al.
Molecular Cancer Therapeutics
|
June 9, 2012
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors
Howard A Burris, Afshin Dowlati, Rebecca A Moss, et al.
Page
of 30